Drug Shortage Report for AUBAGIO
| Report ID | 159348 |
| Drug Identification Number | 02416328 |
| Brand name | AUBAGIO |
| Common or Proper name | Teriflunomide tablets 14 mg |
| Company Name | SANOFI GENZYME, A DIVISION OF SANOFI-AVENTIS CANADA INC |
| Market Status | MARKETED |
| Active Ingredient(s) | TERIFLUNOMIDE |
| Strength(s) | 14MG |
| Dosage form(s) | TABLET |
| Route of administration | ORAL ORAL |
| Packaging size | 14 mg |
| ATC code | L04AA |
| ATC description | IMMUNOSUPPRESSANTS |
| Reason for shortage | Other (Please describe in comments) |
| Anticipated start date | 2022-04-28 |
| Actual start date | |
| Estimated end date | 2022-05-11 |
| Actual end date | 2022-05-03 |
| Shortage status | Resolved |
| Updated date | 2022-05-04 |
| Company comments | Manufacturing delay. The availability date represents estimated availability at the main Sanofi warehouse. Availability dates at a customer’s usual distributor warehouse may vary. Pharmacies are invited to communicate with their preferred distributor to obtain the product availability date. |
| Health Canada comments | |
| Tier 3 Status | No |
| Company contact information | Customer service contact info: 1-800-265-7927 |
Version History
Click on "Compare" below to view the full report history and compare to other versions.
| Version Number | Date Updated | Language | |
|---|---|---|---|
| v5 | 2022-05-04 | French | Compare |
| v4 | 2022-05-04 | English | Compare |
| v3 | 2022-04-29 | English | Compare |
| v2 | 2022-04-25 | French | Compare |
| v1 | 2022-04-25 | English | Compare |
Showing 1 to 5 of 5